3,379 Shares in Corteva, Inc. (NYSE:CTVA) Acquired by Koshinski Asset Management Inc.

Koshinski Asset Management Inc. purchased a new position in shares of Corteva, Inc. (NYSE:CTVAFree Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 3,379 shares of the company’s stock, valued at approximately $213,000.

Other institutional investors have also modified their holdings of the company. Flagship Wealth Advisors LLC purchased a new stake in shares of Corteva in the 4th quarter valued at approximately $25,000. Pinney & Scofield Inc. acquired a new position in shares of Corteva during the 4th quarter worth $27,000. LGT Financial Advisors LLC acquired a new stake in shares of Corteva in the fourth quarter worth about $31,000. Valley National Advisers Inc. lifted its stake in shares of Corteva by 85.9% in the first quarter. Valley National Advisers Inc. now owns 526 shares of the company’s stock worth $33,000 after buying an additional 243 shares during the last quarter. Finally, J.Safra Asset Management Corp bought a new stake in Corteva during the fourth quarter valued at about $37,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Up 0.3%

Shares of NYSE CTVA opened at $77.24 on Friday. The stock has a market capitalization of $52.69 billion, a P/E ratio of 47.09, a PEG ratio of 1.96 and a beta of 0.76. The firm’s 50 day simple moving average is $69.79 and its two-hundred day simple moving average is $63.82. Corteva, Inc. has a one year low of $50.30 and a one year high of $77.41. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.44 and a quick ratio of 1.00.

Corteva (NYSE:CTVAGet Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.25. Corteva had a return on equity of 7.84% and a net margin of 6.77%. The company had revenue of $4.42 billion for the quarter, compared to analysts’ expectations of $4.56 billion. During the same period last year, the firm earned $0.89 earnings per share. Corteva’s quarterly revenue was down 1.7% on a year-over-year basis. As a group, analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Investors of record on Friday, May 2nd were given a $0.17 dividend. The ex-dividend date was Monday, June 2nd. This represents a $0.68 annualized dividend and a yield of 0.88%. Corteva’s dividend payout ratio (DPR) is presently 41.46%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on CTVA shares. KeyCorp upped their price target on Corteva from $71.00 to $72.00 and gave the company an “overweight” rating in a report on Friday, May 9th. Morgan Stanley lifted their target price on shares of Corteva from $65.00 to $71.00 and gave the company an “overweight” rating in a research note on Friday, May 9th. Citigroup upped their price target on shares of Corteva from $75.00 to $78.00 and gave the stock a “buy” rating in a research report on Friday, May 9th. Jefferies Financial Group restated a “buy” rating on shares of Corteva in a research report on Friday, June 6th. Finally, UBS Group raised their price objective on shares of Corteva from $74.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday, May 8th. Three investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $72.08.

Read Our Latest Research Report on Corteva

Corteva Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

See Also

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.